Drug Interactions between pembrolizumab and ramucirumab
This report displays the potential drug interactions for the following 2 drugs:
- pembrolizumab
- ramucirumab
Interactions between your drugs
No interactions were found between pembrolizumab and ramucirumab. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
pembrolizumab
A total of 13 drugs are known to interact with pembrolizumab.
- Pembrolizumab is in the drug class anti-PD-1 monoclonal antibodies.
-
Pembrolizumab is used to treat the following conditions:
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Carcinoma
- Gastric Cancer
- Head and Neck Cancer
- Hepatocellular Carcinoma
- Hodgkin's Lymphoma
- Melanoma
- Melanoma, Metastatic
- Merkel Cell Carcinoma
- Non-Small Cell Lung Cancer
- Primary Mediastinal Large B-cell Lymphoma
- Renal Cell Carcinoma
- Small Cell Lung Cancer
- Solid Tumors
- Squamous Cell Carcinoma
- Urothelial Carcinoma
ramucirumab
A total of 129 drugs are known to interact with ramucirumab.
- Ramucirumab is in the drug class VEGF/VEGFR inhibitors.
- Ramucirumab is used to treat the following conditions:
Drug and food interactions
No interactions were found. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.